Skip to content

Solid Biosciences Inc. SLDB Retained Earnings

Retained Earnings at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$4.55B+2.4%
Biogen logo
BiogenBIIB
$20.87B+7.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$589.6M+11,225%
Insmed logo
InsmedINSM
-$5.8B-25.6%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$1.52B-42.4%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$753.71M-20.8%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$910.66M+135%
Enterprise value$634.23M+223%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s retained earnings?
Solid Biosciences Inc. (SLDB) reported retained earnings of -$1.01B in Q1 2026.
How has Solid Biosciences Inc.'s retained earnings changed year-over-year?
Solid Biosciences Inc.'s retained earnings decreased by 23.3% year-over-year, from -$822.73M to -$1.01B.
What is the long-term trend for Solid Biosciences Inc.'s retained earnings?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s retained earnings has grown at a 18.8% compound annual growth rate (CAGR), from -$404.57M to -$957.78M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.